{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:28:38Z","timestamp":1787671718512,"version":"build-2736575974"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"19","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Am Acad Orthop Surg","JAAOS"],"published-print":{"date-parts":[[2019,10,1]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Tranexamic acid (TXA) is increasingly used to reduce blood loss in lower extremity arthroplasty, but limited data exist for its effectiveness in patients undergoing shoulder arthroplasty. We aimed to use national data to assess the frequency of use and effectiveness of TXA in patients undergoing shoulder arthroplasty.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Using national claims data from patients undergoing shoulder arthroplasty (Premier Healthcare; 2010 to 2016; n = 82,512; 429 hospitals), we categorized patients according to whether they received perioperative TXA. Multilevel multivariable regression models measured associations between TXA and blood transfusion risk, combined complications (including thromboembolic events, acute renal failure, cerebral infarction, and acute myocardial infarction), and length and cost of hospitalization. Odds ratios (ORs) and 95% confidence intervals (CIs) are reported.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Overall, TXA was used in 12.8% (n = 10,582) of patients with a strong increasing trend. After adjustment for relevant covariates, TXA use (compared with no TXA use) was associated with a 36% decrease in transfusion risk (OR, 0.64; 95% CI, 0.52 to 0.77;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05) and a 35% decreased risk for combined complications (OR, 0.65; 95% CI, 0.50 to 0.83;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05). Moreover, TXA use was associated with 6.2% shorter hospital stay (95% CI, \u22128.0% to \u22124.4%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05), whereas no difference was observed with the cost of hospitalization.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>In this first large-scale study assessing TXA use and effectiveness in patients undergoing shoulder arthroplasty, we found that although TXA utilization is still low, it is associated with a marked decrease in transfusion risk with no increases in complication risk. Effects on the length and cost of hospitalization appeared minor. Future studies should assess whether higher volumes of TXA utilization would translate into more gains on the length and cost of hospitalization.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Level of Evidence:<\/jats:title>\n                    <jats:p>Level III<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5435\/jaaos-d-18-00206","type":"journal-article","created":{"date-parts":[[2019,4,7]],"date-time":"2019-04-07T20:48:10Z","timestamp":1554670090000},"page":"736-742","source":"Crossref","is-referenced-by-count":22,"title":["Utilization and Real-world Effectiveness of Tranexamic Use in Shoulder Arthroplasty: A Population-based Study"],"prefix":"10.5435","volume":"27","author":[{"given":"Shawn G.","family":"Anthony","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana C.","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Cagle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jashvant","family":"Poeran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Zubizarreta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhu","family":"Mazumdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leesa M.","family":"Galatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230714","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1016\/j.jse.2014.06.055","article-title":"The contribution of reverse shoulder arthroplasty to utilization of primary shoulder arthroplasty","volume":"23","author":"Jain","year":"2014","journal-title":"J Shoulder Elbow Surg"},{"key":"R2-20230714","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jse.2012.04.013","article-title":"Blood transfusion associated with shoulder arthroplasty","volume":"22","author":"Hardy","year":"2013","journal-title":"J Shoulder Elbow Surg"},{"key":"R3-20230714","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jse.2009.05.001","article-title":"Predicting transfusion in shoulder arthroplasty","volume":"19","author":"Schumer","year":"2010","journal-title":"J Shoulder Elbow Surg"},{"key":"R4-20230714","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.jse.2005.03.006","article-title":"Incidence and risk factors for blood transfusion in shoulder arthroplasty","volume":"14","author":"Sperling","year":"2005","journal-title":"J Shoulder Elbow Surg"},{"key":"R5-20230714","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jse.2008.08.005","article-title":"Transfusion after shoulder arthroplasty: An analysis of rates and risk factors","volume":"18","author":"Gruson","year":"2009","journal-title":"J Shoulder Elbow Surg"},{"key":"R6-20230714","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1016\/j.jse.2014.04.008","article-title":"Analysis of perioperative complications in patients after total shoulder arthroplasty and reverse total shoulder arthroplasty","volume":"23","author":"Jiang","year":"2014","journal-title":"J Shoulder Elbow Surg"},{"key":"R7-20230714","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.2106\/JBJS.G.00775","article-title":"Reverse shoulder arthroplasty for the treatment of rotator cuff deficiency","volume":"90","author":"Cuff","year":"2008","journal-title":"J Bone Joint Surg Am"},{"key":"R8-20230714","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jse.2006.01.003","article-title":"Neer award 2005: The grammont reverse shoulder prosthesis: Results in cuff tear arthritis, fracture sequelae, and revision arthroplasty","volume":"15","author":"Boileau","year":"2006","journal-title":"J Shoulder Elbow Surg"},{"key":"R9-20230714","doi-asserted-by":"crossref","first-page":"272","DOI":"10.2106\/JBJS.L.01268","article-title":"Allogeneic blood transfusions and postoperative infections after total hip or knee arthroplasty","volume":"96","author":"Friedman","year":"2014","journal-title":"J Bone Joint Surg Am"},{"key":"R10-20230714","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.arth.2016.08.026","article-title":"Allogeneic blood transfusion is a significant risk factor for surgical-site infection following total hip and knee arthroplasty: A meta-analysis","volume":"32","author":"Kim","year":"2017","journal-title":"J Arthroplasty"},{"key":"R11-20230714","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2165\/11209070-000000000-00000","article-title":"Tranexamic acid: A review of its use in the treatment of hyperfibrinolysis","volume":"72","author":"McCormack","year":"2012","journal-title":"Drugs"},{"key":"R12-20230714","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1302\/0301-620X.93B12.26989","article-title":"Tranexamic acid in total knee replacement: A systematic review and meta-analysis","volume":"93","author":"Alshryda","year":"2011","journal-title":"J Bone Joint Surg Br"},{"key":"R13-20230714","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2174\/1874325001408010250","article-title":"Tranexamic acid reduces blood loss and transfusion in patients undergoing total knee arthroplasty without Tourniquet: A prospective randomized controlled trial","volume":"8","author":"Bidolegui","year":"2014","journal-title":"Open Orthop J"},{"key":"R14-20230714","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1007\/s11999-013-3446-0","article-title":"Topical tranexamic acid reduces blood loss and transfusion rates associated with primary total hip arthroplasty","volume":"472","author":"Chang","year":"2014","journal-title":"Clin Orthop Relat Res"},{"issue":"8 suppl","key":"R15-20230714","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.arth.2013.03.038","article-title":"A prospective double-blind placebo controlled trial of topical tranexamic acid in total knee arthroplasty","volume":"28","author":"Georgiadis","year":"2013","journal-title":"J Arthroplasty"},{"key":"R16-20230714","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.arth.2013.09.005","article-title":"Topical tranexamic acid reduces transfusion rates in total hip and knee arthroplasty","volume":"29","author":"Gilbody","year":"2014","journal-title":"J Arthroplasty"},{"key":"R17-20230714","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.arth.2013.10.005","article-title":"Topical administration of tranexamic acid in primary total hip and total knee arthroplasty","volume":"29","author":"Martin","year":"2014","journal-title":"J Arthroplasty"},{"key":"R18-20230714","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1302\/0301-620X.93B1.24984","article-title":"Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement","volume":"93","author":"Sukeik","year":"2011","journal-title":"J Bone Joint Surg Br"},{"key":"R19-20230714","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2106\/JBJS.K.00873","article-title":"Effectiveness and safety of tranexamic acid in reducing blood loss in total knee arthroplasty: A meta-analysis","volume":"94","author":"Yang","year":"2012","journal-title":"J Bone Joint Surg Am"},{"key":"R20-20230714","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/j.jse.2015.07.029","article-title":"Neer award 2015: A randomized, prospective evaluation on the effectiveness of tranexamic acid in reducing blood loss after total shoulder arthroplasty","volume":"24","author":"Gillespie","year":"2015","journal-title":"J Shoulder Elbow Surg"},{"key":"R21-20230714","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.jse.2016.02.002","article-title":"Tranexamic acid decreases blood loss in total shoulder arthroplasty and reverse total shoulder arthroplasty","volume":"25","author":"Abildgaard","year":"2016","journal-title":"J Shoulder Elbow Surg"},{"key":"R22-20230714","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jse.2015.09.014","article-title":"Tranexamic acid decreases blood loss after total shoulder arthroplasty","volume":"25","author":"Friedman","year":"2016","journal-title":"J Shoulder Elbow Surg"},{"key":"R23-20230714","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1302\/0301-620X.99B8.BJJ-2016-1205.R1","article-title":"The effect of intravenous tranexamic acid on blood loss and early post-operative pain in total shoulder arthroplasty","volume":"99-B","author":"Pauzenberger","year":"2017","journal-title":"Bone Joint J"},{"key":"R24-20230714","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/j.jse.2017.01.005","article-title":"Intravenous tranexamic acid reduces total blood loss in reverse total shoulder arthroplasty: A prospective, double-blinded, randomized, controlled trial","volume":"26","author":"Vara","year":"2017","journal-title":"J Shoulder Elbow Surg"},{"key":"R25-20230714","first-page":"1110","article-title":"Transforming the premier perspective hospital database into the observational medical outcomes partnership (OMOP) common data model","volume":"2","author":"Makadia","year":"2014","journal-title":"EGEMS (Wash DC)"},{"key":"R26-20230714","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1471-2288-7-34","article-title":"A simulation study of sample size for multilevel logistic regression models","volume":"7","author":"Moineddin","year":"2007","journal-title":"BMC Med Res Methodol"},{"key":"R27-20230714","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"key":"R28-20230714","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"key":"R29-20230714","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1471-2288-12-68","article-title":"A review of statistical estimators for risk-adjusted length of stay: Analysis of the Australian and New Zealand intensive care adult patient data-base, 2008-2009","volume":"12","author":"Moran","year":"2012","journal-title":"BMC Med Res Methodol"},{"key":"R30-20230714","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0149-2918(01)80052-7","article-title":"Dealing with skewed data: An example using asthma-related costs of medicaid clients","volume":"23","author":"Rascati","year":"2001","journal-title":"Clin Ther"},{"key":"R31-20230714","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.arth.2014.04.029","article-title":"National trends in the utilization of blood transfusions in total hip and knee arthroplasty","volume":"29","author":"Yoshihara","year":"2014","journal-title":"J Arthroplasty"},{"key":"R32-20230714","first-page":"279","article-title":"Intraarticular administration of tranexamic acid is safe and effective in total knee arthroplasty patients at high-risk for thromboembolism","volume":"30","author":"Delanois","year":"2016","journal-title":"Surg Technol Int"},{"key":"R33-20230714","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/j.arth.2014.03.011","article-title":"Comparison of intravenous versus topical tranexamic acid in total knee arthroplasty: A prospective randomized study","volume":"29","author":"Patel","year":"2014","journal-title":"J Arthroplasty"},{"key":"R34-20230714","doi-asserted-by":"crossref","first-page":"g4829","DOI":"10.1136\/bmj.g4829","article-title":"Tranexamic acid use and postoperative outcomes in patients undergoing total hip or knee arthroplasty in the United States: Retrospective analysis of effectiveness and safety","volume":"349","author":"Poeran","year":"2014","journal-title":"BMJ"},{"key":"R35-20230714","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/j.arth.2014.07.019","article-title":"Comparison of topical and intravenous tranexamic acid on blood loss and transfusion rates in total hip arthroplasty","volume":"29","author":"Wei","year":"2014","journal-title":"J Arthroplasty"},{"key":"R36-20230714","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s00264-016-3296-y","article-title":"Topical versus intravenous tranexamic acid in total knee arthroplasty: A meta-analysis of randomized controlled trials","volume":"41","author":"Wang","year":"2017","journal-title":"Int Orthop"},{"key":"R37-20230714","doi-asserted-by":"crossref","first-page":"e0177011","DOI":"10.1371\/journal.pone.0177011","article-title":"Intraoperative tranexamic acid is associated with postoperative stroke in patients undergoing cardiac surgery","volume":"12","author":"Zhou","year":"2017","journal-title":"PLoS One"},{"key":"R38-20230714","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.knee.2013.05.014","article-title":"Topical tranexamic acid in total knee replacement: A systematic review and meta-analysis","volume":"20","author":"Panteli","year":"2013","journal-title":"Knee"},{"key":"R39-20230714","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1016\/j.arth.2018.08.002","article-title":"Tranexamic acid use in total joint arthroplasty: The clinical practice guidelines endorsed by the American Association of Hip and Knee Surgeons, American Society of Regional Anesthesia and Pain Medicine, American Academy of Orthopaedic Surgeons, Hip Society, and Knee Society","volume":"33","author":"Fillingham","year":"2018","journal-title":"J Arthroplasty"},{"key":"R40-20230714","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1213\/XAA.0000000000000667","article-title":"Acute coronary artery thrombus after tranexamic acid during total shoulder arthroplasty in a patient with coronary stents: A case report","volume":"10","author":"Bridges","year":"2018","journal-title":"A A Pract"},{"key":"R41-20230714","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/230949901602400103","article-title":"Clinical and financial benefits of intra-articular tranexamic acid in total knee arthroplasty","volume":"24","author":"Goyal","year":"2016","journal-title":"J Orthop Surg (Hong Kong)"},{"key":"R42-20230714","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1016\/j.arth.2018.03.031","article-title":"The safety of tranexamic acid in total joint arthroplasty: A direct meta-analysis","volume":"33","author":"Fillingham","year":"2018","journal-title":"J Arthroplasty"}],"container-title":["Journal of the American Academy of Orthopaedic Surgeons"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.5435\/JAAOS-D-18-00206","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:49:12Z","timestamp":1787669352000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.5435\/JAAOS-D-18-00206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,1]]},"references-count":42,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.5435\/jaaos-d-18-00206","relation":{},"ISSN":["1067-151X","1940-5480"],"issn-type":[{"value":"1067-151X","type":"print"},{"value":"1940-5480","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,1]]}}}